India: Pharma Exports from Visakhapatnam Set to Become Hassle-Free
Export of drug and pharmaceuticals from Visakhapatnam sea port and airport is set to become smoother. To facilitate exports, a team of officials, including an assistant drug controller (ADC), drug inspector and an assistant drug inspector, has been appointed to function from this port city.
According to Mr. Uday Bhaskar, Director-General, Pharmaceutical Exports Promotion Council (Pharmexcil), drug manufacturers and exporters were having difficulty till now in exporting by sea and air due to the non-availability of officials to complete the mandatory ‘No Objection Certificate (NOC)’ process.
“Though Visakhapatnam air and sea ports have been notified as eligible for export/import of drugs and pharmaceuticals two years ago, ADC/drug inspectors were not appointed and exporters had to go to Hyderabad for completing all formalities,” Mr. Uday Bhaskar said.
Pharmexcil brought the issue to the notice of the Central Drug Standards Control Organisation (CDSCO) which facilitated the appointment of the official team, he said. This will be an advantage for drug exports as Visakhapatnam has a pharma city with presence of many global players such as Eisai Pharma and Indian multinational drug-makers. There have been plans to set up a second pharma city near Nakkappli in Visakhapatnam district as well.
According to industry estimates, post-bifurcation of Andhra Pradesh in 2014, north Andhra region in the State is poised to emerge as a major destination for pharma firms due to its strategic location besides airport, highway and sea connectivity. As Telangana has no sea port, few bulk drug manufacturers from Hyderabad, which is known as bulk drug capital of India, have also been exporting from Visakhapatnam.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Three Major Indian Chemical Investments Target China's PC Exports
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
-
India Imposes Anti-Dumping Duties on Chinese vitamin A Palmitate and Insoluble Sulfur Products
-
Indian Government Increases Excise Duty on Petrol and Diesel
Recommend Reading
-
The Cold Cycle: PVC Market’s Chill and Faint Light Ahead
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
Echoes of Overcapacity: The Structural Anxiety of China’s EVA Industry Chain
-
Mitsui, Idemitsu, and Sumitomo Restructure Polyolefins Business
-
Turkey’s BOTAS Expands LNG Supply Portfolio at Gastech 2025
-
April Benzene Market Trend Summary (April 1-30, 2026) in China
-
In April, the Shandong Asphalt Market First Declined Then Rose, What Will Happen Next?
-
Costs Decline, Consumption Weakens—ABS Prices Drop Sharply in April
-
Upstream Decline & Lackluster Trading Activity: April PC Prices Fall from High Levels
-
Supply Tightening Dominates the Market, Acrylic Acid Prices Steady with an Uptick